Search company, investor...

Founded Year



Series A | Alive

Total Raised


Last Raised

$20M | 1 yr ago

About MDI Health

MDI Health develops a framework for artificial pharmacology intelligence. The company uses technology, methodology, and algorithms to ensure early detection of potential medication-related problems (MRPs) during a drug treatment regimen. It is an add-on to electronic health records systems (EHRs) supporting physicians, helping them make more informed medication-related decisions, and providing personalized multi-drug treatment. The company was founded in 2019 and is based in Tel Aviv, Israel.

Headquarters Location

Tel Aviv, 60198,



MDI Health's Products & Differentiators

    Artificial Pharmacology Intelligence

    MDI's mission is to prevent medication-related problems at scale. Our Artificial Pharmacology Intelligence platform performs multi-dimensional, context-based analyses of thousands of pharmacological and patient-specific parameters, to autonomously optimize personalized medication treatment at scale. Our end-to-end AI system automates the process of identifying high-risk members for specific ADRs, conducts a holistic analysis of a patient’s drug-related risks, and provides high-impact recommendations to reduce risks and save $1000’s PMPY


Expert Collections containing MDI Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

MDI Health is included in 2 Expert Collections, including Artificial Intelligence.


Artificial Intelligence

11,383 items

Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.


Digital Health

10,804 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

Latest MDI Health News

MDI Health Frequently Asked Questions (FAQ)

  • When was MDI Health founded?

    MDI Health was founded in 2019.

  • Where is MDI Health's headquarters?

    MDI Health's headquarters is located at Tel Aviv.

  • What is MDI Health's latest funding round?

    MDI Health's latest funding round is Series A.

  • How much did MDI Health raise?

    MDI Health raised a total of $27.02M.

  • Who are the investors of MDI Health?

    Investors of MDI Health include JumpSpeed Ventures, Fresh.Fund, Intel Capital, Arc Impact, WellTech Ventures and 13 more.

  • Who are MDI Health's competitors?

    Competitors of MDI Health include Tabula Rasa Healthcare and 2 more.

  • What products does MDI Health offer?

    MDI Health's products include Artificial Pharmacology Intelligence .


Compare MDI Health to Competitors

RxAnte Logo

RxAnte is a company that focuses on predictive analytics and clinical services in the healthcare industry. The company offers solutions that improve medication use and health outcomes, including patented platforms that leverage predictive and decision analytics, advanced program evaluation methods, and a web-based workflow solution. RxAnte primarily serves health plans and providers. It was founded in 2011 and is based in Portland, Maine. RxAnte operates as a subsidiary of Millennium Laboratories.

Press Ganey Logo
Press Ganey

Press Ganey focuses on transforming the healthcare experience, operating within the healthcare and technology sectors. The company offers a platform that uses advanced analytics and machine learning to gather and analyze healthcare data, providing insights to improve patient and employee experiences, safety, and quality. Its services are primarily utilized by health systems and providers, health plans, and life sciences industries. It was founded in 1985 and is based in South Bend, Indiana.

Wellnecity Group

Wellnecity Group is a company focused on providing business intelligence for employer healthcare in the health tech industry. The company offers an operating platform for self-insured health plans, using advanced analytics and real-time cost monitoring to help employers lower healthcare costs and improve outcomes. Their primary customers are self-funded employers, benefits advisors, and health plan vendors. It was founded in 2015 and is based in Winston Salem, North Carolina.

Nuna Logo

Nuna is a company that focuses on healthcare technology, specifically in the domain of Value Based Care. The company offers a platform that facilitates intelligent payment models, seamless operations, and fast payments for healthcare providers. This platform is primarily used in the healthcare industry. It was founded in 2010 and is based in San Francisco, California.

Apixio Logo

Apixio focuses on healthcare artificial intelligence (AI) solutions, operating within the healthcare and technology sectors. The company offers a range of services including risk adjustment, clinical guidance, payment integrity, health data management, and utilization management, all powered by artificial intelligence. These services aim to improve administrative, clinical, and financial outcomes by delivering actionable insights from healthcare data. Apixio primarily serves health plans, providers, and Accountable Care Organizations (ACOs). It was founded in 2009 and is based in San Mateo, California.


Pharmesol is an artificial intelligence (AI)--enabled company focused on the healthcare and pharmaceutical industry. The company offers an automated assistant for pharmacies, designed to handle frequent conversations and administrative tasks, thereby improving patient experience. Its primary market is the healthcare industry. It was founded in 2023 and is based in Auburndale, Massachusetts.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.